Modification of von Willebrand disease after liver transplantation.
Schulman
S
S
Ericzon
B G
BG
Eleborg
L
L
D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000601:surgery; D003131:Combined Modality Therapy; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000637:transplantation; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D008099:Liver / Q000098:blood supply; D008113:Liver Neoplasms / Q000150:complications* / Q000601:surgery; D016031:Liver Transplantation; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D014842:von Willebrand Diseases / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D014841:von Willebrand Factor / Q000378:metabolism* / Q000627:therapeutic use
D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin